<DOC>
	<DOCNO>NCT00247325</DOCNO>
	<brief_summary>In treatment coronary heart disease major cause heart attack , direct mechanical treatment catheter coronary angiography , coronary balloon intervention stenting intervention mainstay therapy recent year . In procedure , use contrast medium , may cause kidney toxicity especially patient underlie kidney disease decrease kidney function . We intend find contrast agent less kidney toxicity catheter base treatment coronary arterial disease patient underlie decreased kidney function</brief_summary>
	<brief_title>RECOVER : Comparison Renal Toxicity Between Visipaque ( Iodixanol ) Hexabrix ( Ioxaglate ) Renal Insufficiency Undergoing Coronary Angiography</brief_title>
	<detailed_description>Iodixanol , nonionic , dimeric , iso-osmolar contrast medium ( IOCM ) , may less nephrotoxic nonionic , monomeric , low-osmolar contrast medium ( LOCMs ) high-risk patient . We compare nephrotoxicity iodixanol ioxaglate , ionic , dimeric LOCM , patient renal impairment .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<criteria>creatinine clearance rate â‰¤60 mL/min use CockcroftGault formula Patients undergo coronary catheterization Age 19 19. pregnancy lactation receive contrast medium within 7 day study entry emergent coronary angiography acute renal failure endstage renal disease require dialysis history hypersensitivity reaction contrast medium cardiogenic shock pulmonary edema multiple myeloma mechanical ventilation parenteral use diuretic use Nacetylcysteine use metformin nonsteroidal antiinflammatory drug within 48 hour procedure .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2005</verification_date>
	<keyword>Kidney failure</keyword>
	<keyword>Contrast medium</keyword>
	<keyword>Iodixanol</keyword>
	<keyword>Ioxaglate</keyword>
</DOC>